Heart rate

FreeYond Debuts in Malaysia- The launch marks FreeYond's formal entry into the Southeast Asian market, starting with Malaysia

Retrieved on: 
Wednesday, March 22, 2023
Communication, Music, ROM, Electronics, TWS, Diaphragm, YB, Human, M5, Tech, RM, GB, IP68, Walking, Work, RAM, IPX4, Sound, Perspiration, Heart rate, Health, Rain, Mobile phone, Video game, Camera, Cassette tape, ASEAN, F1, F9, Upload

The successful launch establishes FreeYond as a key player and force to be reckoned with in the market.

Key Points: 
  • The successful launch establishes FreeYond as a key player and force to be reckoned with in the market.
  • Introducing its cutting-edge technology to consumers in Malaysia marks an important milestone for FreeYond, as it expands its market reach.
  • "Our mission is to provide innovative, user-friendly products to consumers worldwide, and we're glad to bring our products to Malaysia."
  • The company intends to leverage Datuk Eddie’s influence to expand its business in Southeast Asia including Malaysia, Indonesia, Thailand, and Singapore.

Feinstein Institutes researchers use novel imaging technology to study how the brain and body communicate

Retrieved on: 
Tuesday, March 21, 2023
Oncology, Mental Health, Health, Hospitals, Research, Science, Inflammation, Infection, Neuron, Medicine, Diabetes, Inflammatory Bowel Diseases, Vagus nerve, Arthritis, Respiration, Neural engineering, Feinstein Institutes for Medical Research, Cancer, Skull, Brain, Multimedia, Attention, Biomedical engineering, Doctor of Philosophy, Interface (computing), Sensation, PNS, Bangladesh Technical Education Board, Paralysis, Crohn's disease, Neuroscience, Journal, Nervous system, Mouse, Heart rate, Pulmonary hypertension, Credit, Molecular medicine, NIH, Medical research, Rheumatoid arthritis, Disease, Peripheral nervous system, Medical imaging, Medical device, MD

By using calcium imaging technology to monitor neural activity from a cluster of neurons near the base of the skull, scientists hope to discover new clues about how the body communicates with the brain.

Key Points: 
  • By using calcium imaging technology to monitor neural activity from a cluster of neurons near the base of the skull, scientists hope to discover new clues about how the body communicates with the brain.
  • The researchers used imaging of the intact jugular-nodose ganglion – which contains the sensory neurons of the vagus nerve – to directly record neural activity in mice with genetically-encoded calcium indicators.
  • In this new study, Feinstein Institutes’ bioelectronic medicine researchers look at how sensory neurons encode and transmit these important physiological signals in the form of neural activity.
  • At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury.

Altimmune Announces Positive Results from Week 24 Interim Analysis of Pemvidutide MOMENTUM Phase 2 Obesity Trial and 12-Week Phase 1b Type 2 Diabetes Safety Trial

Retrieved on: 
Tuesday, March 21, 2023
Blood pressure, Exercise, Hyperglycemia, Obesity, Dyslipidemia, Diet, AE, NASH, Diabetes, Diarrhea, Week, Liver disease, Principal investigator, Aes, Weight loss, Cardiovascular disease, Constipation, Endocrine & Metabolism Research Institute, Risk, Medicine, Vomiting, Waist, Patient, Physician, LDL, Overweight, Weill Cornell Medicine, Nausea, Heart rate, Research, GI, Safety, Fasting, Female, Glycated hemoglobin, Human, Dietary supplement, Pharmaceutical industry

GAITHERSBURG, Md., March 21, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company (the “Company”), today announced topline results from a Week 24 interim analysis of 160 subjects in its 48-week MOMENTUM Phase 2 obesity trial of pemvidutide along with the results of the 12-week Phase 1b safety trial of pemvidutide in subjects with obesity or overweight and type 2 diabetes.

Key Points: 
  • The trial was designed to enroll approximately 320 subjects with obesity or overweight with at least one co-morbidity and without diabetes.
  • Subjects were randomized 1:1:1:1 to 1.2 mg, 1.8 mg, 2.4 mg pemvidutide or placebo administered weekly for 48 weeks in conjunction with diet and exercise.
  • A pre-specified interim analysis was conducted after 160 subjects completed 24 weeks of treatment.
  • We look forward to completing our 48-week MOMENTUM obesity trial in the fourth quarter of 2023 and initiating a Phase 2 biopsy NASH trial in mid-2023.”

NEW AMAZFIT T-REX ULTRA IS LAUNCHED FOR THE ULTIMATE MULTI-ENVIRONMENT OUTDOOR GPS SMARTWATCH EXPERIENCE

Retrieved on: 
Monday, March 20, 2023
AMOLED, GPS, AliExpress, SAE 316L stainless steel, GoPro, Carbon, Element, Amazon, Philosophy, Zepp, Running, Heart rate, NYSE, Television, Satellite navigation device, Amazfit, Strava

Crafted with premium materials, this new ultra-tough outdoor GPS smartwatch is the most high-end addition to the Amazfit T-Rex series.

Key Points: 
  • Crafted with premium materials, this new ultra-tough outdoor GPS smartwatch is the most high-end addition to the Amazfit T-Rex series.
  • Setting a new benchmark for smartwatches built for professional-level outdoor exploration, the Amazfit T-Rex Ultra unites the brand's outdoor-oriented product line under the new philosophy of Brave Your Adventure.
  • Along with GPS tracking that's ultra-precise even in environments with high mountains and dense forests, the route navigation function has been upgraded.
  • It is now available at Amazfit stores, Amazon and AliExpress, with prices starting from $399.99 USD (prices may vary depending on location).

Biometrics Leader LifeQ Revolutionizes Healthcare with Disease Screening and Early Detection

Retrieved on: 
Monday, March 20, 2023
Mont Blanc, Fossil, Blood pressure, Medicine, Night, Probability, Photoplethysmogram, Cardiomyopathy, TAG Heuer, Health, Bradycardia, Classification, HOCM, Atrial fibrillation, Respiratory rate, COVID-19, Sleep, Restless legs syndrome, Arteriosclerosis, Narcolepsy, Sleep apnea, Acute (medicine), Tachycardia, Hypersomnia, Hypertension, Aortic stenosis, Insomnia, PLMD, Patient, Rapid eye movement sleep behavior disorder, Physician, Cardiovascular disease, PPG, Korea Disease Control and Prevention Agency, Diagnosis, Heart rate, Skin temperature, Chronic condition, Sleepwalking, Bigeminy, Conditional sentence, Disease, REM, Pharmaceutical industry, Medical device, Suunto

ATLANTA, March 20, 2023 /PRNewswire/ -- LifeQ, the company that uses globally-recognized watch brands to gather personalized, clinical-grade data, announced it can detect as many as 40 sleep and cardiovascular disorders with smart watches and other wearable devices, with an anticipated 100 diseases and disorders within the next two years—revolutionizing healthcare and improving consumers' lives. LifeQ co-founders Laurence (Laurie) Olivier, CEO, and Dr. Franco du Preez, Chief Science Officer, made the announcement.

Key Points: 
  • LifeQ co-founders Laurence (Laurie) Olivier, CEO, and Dr. Franco du Preez, Chief Science Officer, made the announcement.
  • LifeQ-enabled devices will help busy clinicians to detect important medical conditions, enable data-driven disease classification as well as facilitate disease prevention.
  • Screening for and flagging disease using wearables is possible through LifeQ's unique combination of photoplethysmography (PPG) and computational systems biology approach.
  • Wearable devices will soon enable insights for hundreds of diseases, providing a personalized action plan and a truly preventative approach to healthcare.

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Retrieved on: 
Monday, March 20, 2023
Long COVID, CSE, Therapy, DSMB, Hospital, Cystinuria, Fever, COVID-19, Secure, Coronavirus, Injury, Research, COVID, Type, Disorder, Cough, Data monitoring committee, RVV, Patient, Risk, Heart rate, FDA, Death, Study, Long, Safety, Pharmaceutical industry, Medical imaging

On March 8th, 2023, the Company announced that it had received the Type C meeting written responses from the FDA to obtain agreement on the proposed protocol endpoints for the Company’s Study.

Key Points: 
  • On March 8th, 2023, the Company announced that it had received the Type C meeting written responses from the FDA to obtain agreement on the proposed protocol endpoints for the Company’s Study.
  • Although the Study was originally designed for a ‘hospitalization or death’ primary endpoint, and it completed enrollment of almost three-quarters of the Study’s recruitment goal and recorded specific clinical symptoms (i.e.
  • ischemia-reperfusion injury , cystinuria ), fast track, and breakthrough therapy designations; and
    Secure alliances with strategic partners, including pharmaceutical companies, to achieve Bucillamine’s full commercial potential.
  • The Company is not making any express or implied claims that its product has the ability to eliminate or cure COVID-19 (SARS-2 Coronavirus) at this time.

Electronic Skin Patches: Transforming Everyday Life, Says IDTechEx

Retrieved on: 
Monday, March 20, 2023
CGM, Communication, Holter, Life, Diabetes, Workplace, Radiation monitoring, Ovulation, Skin, Record, Temperature, Attention, Biomarker, PepsiCo, Athlete, Thermoregulation, Heat injury, Vital signs, Patient, Risk, Fertility, Sport, Himawari (satellites), GX, Heart rate, Health, BBT, Perspiration, Gatorade, Medical device, Cosmetics, Birth control, Epicor

The combined value of cardiac and diabetes applications is estimated to be worth US$13.2 billion, according to IDTechEx in their recent report " Electronic Skin Patches 2023-2033 ".

Key Points: 
  • The combined value of cardiac and diabetes applications is estimated to be worth US$13.2 billion, according to IDTechEx in their recent report " Electronic Skin Patches 2023-2033 ".
  • This article delves into the exciting potential of electronic skin patches in shaping everyday life.
  • As it stands, electronic skin patches have found great success in healthcare applications such as cardiac rhythm and blood glucose monitoring, while the consumer market for electronic skin patches has been smaller and challenging to navigate.
  • Overall, the consumer market for electronic skin patches is expected to grow, and in their report " Electronic Skin Patches 2023-2033 ", IDTechEx predicts that temperature sensing will be the fastest growing area, with a CAGR of 26.5%.

Electronic Skin Patches: Transforming Everyday Life, Says IDTechEx

Retrieved on: 
Monday, March 20, 2023
CGM, Communication, Holter, Life, Diabetes, Workplace, Radiation monitoring, Ovulation, Skin, Record, Temperature, Attention, Biomarker, PepsiCo, Athlete, Thermoregulation, Heat injury, Vital signs, Patient, Risk, Fertility, Sport, Himawari (satellites), GX, Heart rate, Health, BBT, Perspiration, Gatorade, Medical device, Cosmetics, Birth control, Epicor

The combined value of cardiac and diabetes applications is estimated to be worth US$13.2 billion, according to IDTechEx in their recent report " Electronic Skin Patches 2023-2033 ".

Key Points: 
  • The combined value of cardiac and diabetes applications is estimated to be worth US$13.2 billion, according to IDTechEx in their recent report " Electronic Skin Patches 2023-2033 ".
  • This article delves into the exciting potential of electronic skin patches in shaping everyday life.
  • As it stands, electronic skin patches have found great success in healthcare applications such as cardiac rhythm and blood glucose monitoring, while the consumer market for electronic skin patches has been smaller and challenging to navigate.
  • Overall, the consumer market for electronic skin patches is expected to grow, and in their report " Electronic Skin Patches 2023-2033 ", IDTechEx predicts that temperature sensing will be the fastest growing area, with a CAGR of 26.5%.

Smarter Aging Calls for Smarter Homes

Retrieved on: 
Thursday, March 16, 2023
Technology, Mobile, Wireless, Men, Retail, Family, Consumer, Home Goods, Residential Building & Real Estate, Construction & Property, IOT (Internet of Things), Specialty, Women, Seniors, Interior Design, Hive, National Council, Cooking, Quality of life, National Council on Aging, Future, Interior, Ageing, Blood pressure, William Werner House, BOOM, Risk, Jean-Baptiste Brondel, Samsung, Temperature, Airbnb, Cognition, Safety, Heart rate, Kool-Aid, Respiratory rate

According to the National Council on Aging, nearly 14 million Americans are aging alone at home.

Key Points: 
  • According to the National Council on Aging, nearly 14 million Americans are aging alone at home.
  • The house is now available for families to experience a short-term Airbnb vacation stay and determine what they might like to incorporate into their own homes while glimpsing into the future of aging in a chic environment.
  • “With technology constantly advancing, it’s easy to feel overwhelmed when faced with endless options,” says Lisa M. Cini , aging expert and founder of The Werner House.
  • Lisa is also the founder of BestLivingTech.com offering tech products that help seniors embrace aging and living independently.

Amazfit Launches GTR Mini in Malaysia

Retrieved on: 
Wednesday, March 15, 2023
Midnight, The Ocean Blue, Life, HD, Zepp, Sport, Glass, Heart rate, Portrait, Video game, Amazfit

KUALA LUMPUR, Mar 15, 2023 - (ACN Newswire) - Zepp Health Corporation (Zepp), a leading smart wearable and health technology specialist, today launched the Amazfit GTR Mini of smartwatches in Malaysia packed with the super-sleek design and all-round functions of the GTR Mini.

Key Points: 
  • KUALA LUMPUR, Mar 15, 2023 - (ACN Newswire) - Zepp Health Corporation (Zepp), a leading smart wearable and health technology specialist, today launched the Amazfit GTR Mini of smartwatches in Malaysia packed with the super-sleek design and all-round functions of the GTR Mini.
  • We are delighted to finally launch the GTR Mini in Malaysia as another addition to our range of smart wearables."
  • The Amazfit GTR Mini is now available at a launch price at RM579, exclusively on Shopee for three days.
  • Find out more about the Amazfit GTR Mini smartwatch at https://www.amazfit.com/my or Amazfit's e-commerce partner platform https://bit.ly/AmazfitMY_Shopee.